Kalp Ritim Bozukluğunda Sezaryen Anestezisi
Synopsis
Hormonal and hemodynamic changes occurring during pregnancy can predispose to cardiac arrhythmias or trigger the recurrence of pre-existing ones. In the management of atrial fibrillation (AF), the most common arrhythmia type in pregnancy, rate control (digoxin, beta-blockers), rhythm control (sotalol, flecainide), and anticoagulation therapy are administered to prevent maternal and fetal complications, whereas amiodarone is contraindicated due to its fetal toxic effects. In evaluating pregnant patients with a pacemaker, ICD, or CRT, pacemaker dependency and the underlying cardiac pathology must be thoroughly examined; during surgery, to prevent electromagnetic interference, devices should be switched to asynchronous mode, ICD shock functions must be turned off, and bipolar cautery should be preferred. In congenital long QT syndrome, beta-blockers form the cornerstone of medical therapy; perioperative anesthetic and antiemetic drugs that prolong the QT interval (e.g., sevoflurane, ondansetron) must be avoided, and pain, anxiety, and sympathetic activation should be minimized. Across all these arrhythmias, the mode of delivery and anesthetic management are determined by the patient's hemodynamic stability and cardiac capacity. While epidural or combined spinal-epidural anesthesia techniques that reduce sympathetic stress are recommended over general anesthesia for cesarean delivery in hemodynamically stable pregnant women, general anesthesia should be preferred in cases with hemodynamic instability or severe heart failure.
References
Ouzounian JG, Elkayam U. Physiologic changes during normal pregnancy and delivery. Cardiol Clin. 2012;30:317–329
Gilson GJ, Samaan S, Crawford MH, et al. Changes in hemodynamics, ventricular remodeling, and ventricular contractility during normal pregnancy: a longitudinal study. Obstet Gynecol. 1997;89:957–962.
Hunter S, Robson SC. Adaptation of the maternal heart in pregnancy. Br Heart J. 1992;68:540–543.
Knotts RJ, Garan H. Cardiac arrhythmias in pregnancy. Semin Perinatol. 2014; 38:285–288.
Silversides CK, Harris L, Haberer K, et al. Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes. Am J Cardiol. 2006;97:1206–1212.
Walsh CA, Manias T, Patient C. Atrial fibrillation in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2008;138:119-120.
January CT, Wann LS, Alpert JS, et al; American College of Cardiology/American Heart Association Task Force on Practice G . 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014; 64:e1–e76.
Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol. 2003;16:153–168.
Franchini M. Haemostasis and pregnancy. Thromb Haemost. 2006;95:401–413.
Rosenkranz A, Hiden M, Leschnik B, et al. Calibrated automated thrombin generation in normal uncomplicated pregnancy. Thromb Haemost. 2008;99:331–337.
Goland S, Elkayam U. Anticoagulation in pregnancy. Cardiol Clin. 2012; 30:395–405.
Salam AM, Ertekin E, van Hagen IM, et al. Atrial Fibrillation or Flutter During Pregnancy in Patients With Structural Heart Disease: Data From the ROPAC (Registry on Pregnancy and Cardiac Disease). JACC Clin Electrophysiol. 2015;1:284-292.
Anugu VR, Nalluri N, Asti D, et al. New-onset lone atrial fibrillation in pregnancy. Ther Adv Cardiovasc Dis. 2016;10:274–276
Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. A reference guide to fetal and neonatal risk. 4th ed. Baltimore, MD: Williams & Wilkins, 1994
Cacciotti L, Passaseo I. Management of Atrial Fibrillation in Pregnancy. J Atr Fibrillation. 2010;3:295.
Hindricks G, Potpara T, Dagres N, et al; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42:373-498.
Katsi V, Georgiopoulos G, Marketou M, et al. Atrial fibrillation in pregnancy: a growing challenge. Curr Med Res Opin. 2017;33:1497-1504.
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al; ESC Scientific Document Group. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39:3165-3241.
Gupta M, Subramanian S, Adlakha P. Anaesthetic Management of Parturient with Acute Atrial Fibrillation for Emergency Caesarean Section. Case Rep Anesthesiol. 2013;2013:807624
Karahan MA, Buyukfirat E, Binici O, et al. Anaesthesia for Caesarean Section in Pregnancies with Cardiac Disease: An Analysis of 63 Cases Review by Literature. İstanbul Med J. 2018;19: 239-245
Langesaeter E, Dragsund M, Rosseland LA. Regional anaesthesia for a Caesarean section in women with cardiac disease: a prospective study. Acta Anaesthesiol Scand. 2010;54:46-54.
Shen CL, Ho YY, Hung YC, et al. Arrhythmias during spinal anesthesia for Cesarean section. Can J Anaesth. 2000;47:393-397.
Rozner MA, Schulman PM. Creating an Anesthesiologist-run Pacemaker and Defibrillator Service: Closing the Perioperative Care Gap for These Patients. Anesthesiology 2015;123:990.
UpToDate (2021). Perioperative management of patients with a pacemaker or implantable cardioverter-defibrillator. 20.03.2021 tarihinde https://www.uptodate.com/contents/perioperative-management-of-patients-with-a-pacemaker-or-implantable-cardioverter-defibrillator?search=Perioperative%20management%20of%20patients%20with%20a%20pacemaker%20or%20implantable%20cardioverter-defibrillator&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1 adresinden ulaşılmıştır.
Hidaka N, Chiba Y, Fukushima K, et al. Pregnant women with complete atrioventricular block: perinatal risks and review of management. Pacing Clin Electrophysiol. 2011;34:1161-1176.
Yost S, McDonald B, Vallejo M. Anesthetic management of a pregnant patient with an automatic implantable cardioverter-defibrillator: a case report. AANA J. 2009;77:29-32.
Ng YT, Cheung MW, Hui YL. Anesthetic management of a parturient implanted with a permanent pacemaker--a case report. Acta Anaesthesiol Sin. 1997;35:107-111.
Gerlach AT, Murphy CV, Dasta JF. An updated focused review of dexmedetomidine in adults. Ann Pharmacother. 2009;43:2064.
Arnold RW, Jensen PA, Kovtoun TA, et al. The profound augmentation of the oculocardiac reflex by fast acting opioids. Binocul Vis Strabismus Q. 2004;19(4):215-222.
Grover S, Sheth P, Haines DE, et al. Management of cardiac pacemakers in a pregnant patient. Open Journal of Obstetrics and Gynecology. 2014;5:60.
Batra YK, Bali IM. Effect of coagulating and cutting current on a demand pacemaker during transurethral resection of the prostate. A case report. Can Anaesth Soc J. 1978;25:65-66.
Mangar D, Atlas GM, Kane PB. Electrocautery-induced pacemaker malfunction during surgery. Can J Anaesth. 1991;38(5):616-618.
Crossley GH, Poole JE, Rozner MA, et al. The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Heart Rhythm. 2011;8:1114.
Rautaharju PM, Surawicz B, Gettes LS, et al; American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; American College of Cardiology Foundation; Heart Rhythm Society. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol. 2009;53:982-991.
Sauer AJ, Moss AJ, McNitt S, et al. Long QT syndrome in adults. J Am Coll Cardiol. 2007;49:329-337.
Van Noord C, Eijgelsheim M, Stricker BHC. Drug-and non-drug-associated QT interval prolongation. Br J Clin Pharmacol. 2010;70:16-23
O'Neal WT, Singleton MJ, Roberts JD, et al. Association Between QT-Interval Components and Sudden Cardiac Death: The ARIC Study (Atherosclerosis Risk in Communities). Circ Arrhythm Electrophysiol. 2017;10:e005485.
Zamani M, Esmailian M, Yoosefian Z. QT Interval in pregnant and non-pregnant women. Emergency. 2014;2:22-25
Nikoo MH, Khosropanah S, Alborzi S, et al. QT dispersion in young, ideal, and old aged pregnancies. Int Cardiovasc Res J. 2014;8:24-26
Tanindi A, Akgun N, Pabuccu EG, et al. Electrocardiographic Pwave duration, QT interval, T peak to end interval and Tp-e/QT ratio in pregnancy with respect to trimesters. Ann Noninvasive Electrocardiol. 2016;21:169-174
Karahan MA, Büyükfırat E, Altay N, et al. The relationship between gestational week and QT dispersion in cesarean section patients undergoing spinal anaesthesia: A prospective study. Int J Clin Pract. 2021:e14154.
O'Hare M, Maldonado Y, Munro J, et al. Perioperative management of patients with congenital or acquired disorders of the QT interval. Br J Anaesth. 2018;120:629-644.
Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350:1013-1022.
Kaye AD, Volpi-Abadie J, Bensler JM, et al. QT interval abnormalities: risk factors and perioperative management in long QT syndromes and Torsades de Pointes. J Anesth. 2013;27(4):575-587.
Rashba EJ, Zareba W, Moss AJ, et al. Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators. Circulation 1998;97:451–456.
Booker PD, Whyte SD, Ladusans EJ. Long QT syndrome and anaesthesia. Br J Anaesth. 2003;90:349-366.
Wisely NA, Shipton EA. Long QT syndrome and anaesthesia. Eur J Anaesthesiol. 2002;19:853–859.
Khan IA. Clinical and therapeutic aspects of congenital and acquired long QT syndrome. Am J Med. 2002;112:58–66.
Drake E, Preston R, Douglas J. Brief review: anesthetic implications of long QT syndrome in pregnancy. Can J Anaesth. 2007;54(7):561-572.
Khositseth A, Tester DJ, Will ML, et al. Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndrome. Heart Rhythm. 2004;1:60–64.
Mitsutake A, Takeshita A, Kuroiwa A, et al. Usefulness of the Valsalva maneuver in management of the long QT syndrome. Circulation. 1981;63:1029–1035.
Al-Refai A, Gunka V, Douglas J. Spinal anesthesia for cesarean section in a parturient with long QT syndrome. Can J Anesth. 2004;51:993–996.
Katz RI. Some points regarding anesthesia for patients with congenital long QT syndrome. Anesthesiology. 2005;103:1315-6; author reply 1316-1317.
Rasche S, Hubler M. Volatile anesthetics and the long QT syndrome. Anesthesiology. 2005;103:1316; author reply 1316-1317.